The financials
Pediatrix Medical Group, Inc. by the numbers
Pediatrix Medical Group, Inc. (MD) reported revenue of $488M in Q2 2026 (quarter ended June 30, 2026), up 4.0% from the same quarter a year earlier. That came with net income of $40M (8.2% of revenue). For the full year FY2025, revenue was $1.91B (−4.9% year on year) and net income $165M. Its largest product in 2026-Q1 was Health Care Patient Service at $405M, 85% of the disclosed total, just ahead of Hospitals Contracts at 15%.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $488M | $469M | +4.0% |
| Operating income | $57M | $60M | −4.9% |
| Net income | $40M | $39M | +1.5% |
| Diluted EPS | $0.49 | $0.46 | +6.5% |
| Product | Revenue | Share |
|---|---|---|
| Health Care Patient Service | $405M | 85% |
| Hospitals Contracts | $70M | 15% |
| Product And Service Other | $924K | 0.2% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q1 2026Total $476.2M (-3.4%)
Hospitals Contracts grew +7.3% year on yearProduct And Service Other -76% year on year
Segment Latestquarter on quarteryear on year
- Health Care Patient Service$405.4M$405.4MQoQ -4.0%year on year +4.1%-4.0%+4.1%
- Hospitals Contracts$69.9M$69.9MQoQ +3.2%year on year +7.3%+3.2%+7.3%
- Product And Service Other$924.0K$924.0KQoQ -69%year on year -76%-69%-76%